Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Tuesday, January 09, 2024
Pluri Inc. has officially introduced a new business division, PluriCDMO™, dedicated to providing cell therapy manufacturing services as a Contract Development and Manufacturing Organization (CDMO). Leveraging over 20 years of development and ...
read more
Monday, February 09, 2015
Platinum Press, Inc. (PPI) is now a fully certified print packaging supplier for all Walgreens pharmacies. To earn the quality assurance seal, PPI underwent a stringent program administered by Graphic Measures International (GMI), an organization ...
read more
Tuesday, January 07, 2025
Platinum Press, Inc., a provider of printed packaging solutions for the pharmaceutical, natural health and consumer products industries specializing in labels, folding cartons, leaflets, foil lidding and flexible packaging, has completed a $15 ...
read more
Wednesday, August 01, 2018
Platelet BioGenesis has moved into brand new lab space in Cambridge, MA.
read more
Tuesday, October 17, 2017
Plasticell has entered into a collaboration with GSK to use CombiCult, to optimize the directed differentiation of iPSCs to specific blood cell lineages for use by GSK in its therapeutic research.
read more
Wednesday, December 06, 2017
Plasticell announced it will collaborate with Anthony Nolan to progress clinical development of Plasticell’s ex vivo expanded cord-blood derived hematopoietic stem cell product.
read more
Plasticell, a developer of stem cell technologies and cell-based therapies, has signed agreements with the Agency for Science, Technology and Research (A*STAR) and the Nanyang Technological University (NTU) to progress its therapeutic stem cell ...
read more
Plasticell, the biotechnology company using combinatorial technologies for stem cell research and the optimization of cell and gene therapy manufacturing, has announced the signing of a collaboration agreement with the National University of Ireland,...
read more
Wednesday, April 19, 2017
Plasticell, a developer of cell therapies including hematopoietic cell replacement therapies, has partnered with Kings College London to progress preclinical trials of its artificial blood platelet product, manufactured from pluripotent stem cells. ...
read more
Thursday, September 22, 2016
Plasticell, the biotechnology company using combinatorial technologies for stem cell research and optimization of cell and gene therapy manufacturing, has announced it is collaborating with CellSpring, an innovative company that has developed a high ...
read more
Tuesday, January 14, 2025
With this move, PLD is consolidating its divisions with a unified identity that reflects the company’s commitment to developing and manufacturing high quality, liquid and solid dose OTC and Rx products to its customers.
read more
PL BioScience GmbH announced a significant expansion of company headquarters and future manufacturing capabilities to meet the rapidly growing global demand for safe, animal-free cell culture supplements.
read more
PL BioScience GmbH, a German life science company specializing in the production and development of Human Platelet Lysate (HPL) for cell expansion, announced the signing of a Letter of Intent (LOI) with the Korean biotech company DewCell ...
read more
Wednesday, February 28, 2018
ProJect Pharmaceutics announces that it has extended its safety facilities by laboratories dedicated to handle GMO S2 and BSL-2 based biological products.
read more
Tuesday, December 29, 2015
PixarBio Corporation announced today the appointment of Steven Chartier as V.P. of Regulatory Affairs.
read more